Shock

Reading File
Finding Sources
Searching PubMed

shock classification pathophysiology management

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from multiple authoritative textbooks. Let me compile the full answer.

Shock

Definition

Shock is a state of inadequate tissue perfusion leading to cellular hypoxia and, if uncorrected, irreversible organ injury and death. At the subcellular level, it first impairs mitochondrial function, replacing aerobic respiration with anaerobic glycolysis and producing lactic acidosis. Mortality rates exceed 20% across all types. - Rosen's Emergency Medicine, p. 58; Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 134
Key point from Rosen's: Shock can occur with a normal blood pressure, and not all patients with hypotension are in shock. A base deficit more negative than -4 mEq/L or serum lactate >4.0 mmol/L warrants a presumptive diagnosis.

Classification

Four classic categories (with a fifth used clinically):
TypeMechanismClinical Examples
HypovolemicLow blood/plasma volumeHemorrhage, burns, vomiting, diarrhea
CardiogenicPump failure - low cardiac outputMI (>40% myocardium lost), arrhythmia, tamponade, pulmonary embolism
Distributive (Septic)Peripheral vasodilation + blood poolingGram-positive/negative sepsis, fungal sepsis, SIRS
ObstructiveMechanical outflow obstructionPE, tension pneumothorax, cardiac tamponade
NeurogenicLoss of sympathetic toneAcute spinal cord injury
AnaphylacticIgE-mediated acute vasodilationAllergen exposure
  • Robbins, Cotran & Kumar, Table 4.3, p. 134; Rosen's Emergency Medicine, Box 3.1

Pathophysiology

Cellular Level

  • Mitochondria are the first subcellular target
  • Oxygen deficit drives anaerobic glycolysis -> lactic acid accumulation
  • Lactic acidosis blunts vasomotor response -> arteriolar dilation -> microcirculatory pooling
  • Endothelial injury -> DIC risk
  • Lysosomal enzyme leakage worsens the spiral

Three Stages of Shock (Hypovolemic as prototype)

1. Nonprogressive (Compensated) Stage
  • Baroreceptor reflexes, catecholamine release, ADH release, RAAS activation, sympathetic stimulation
  • Result: tachycardia, peripheral vasoconstriction, renal fluid conservation
  • Blood is shunted away from skin to heart and brain
  • Skin: cool, pale, clammy (Note: early septic shock may show warm, flushed skin due to vasodilation)
2. Progressive Stage
  • Tissue hypoxia becomes widespread
  • Anaerobic glycolysis -> lactic acidosis -> arteriolar dilation -> microvascular pooling
  • Cardiac output worsens further; endothelial anoxic injury -> DIC
  • Vital organs begin to fail
3. Irreversible Stage
  • Lysosomal enzymes leak into cells
  • Myocardial contractility worsens (nitric oxide overproduction)
  • Ischemic bowel -> bacterial translocation -> superimposed bacteremic shock
  • Renal failure (ischemic ATN)
  • Death despite intervention
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 134-135

Septic Shock - Pathogenesis in Detail

Septic shock is the most common distributive shock. Mortality ~40%. Triggered most often by gram-positive bacteria, then gram-negative, then fungi.
Key mechanisms:
  1. Pattern recognition: Microbial PAMPs and host DAMPs activate TLRs, G-protein-coupled receptors, and C-type lectin receptors on macrophages, neutrophils, dendritic cells
  2. Cytokine storm: NF-kB activation -> TNF, IL-1, IL-12, IL-18, IFN-gamma, HMGB1, reactive oxygen species, prostaglandins, PAF
  3. Endothelial activation: Upregulated adhesion molecules, increased permeability, capillary leak
  4. Complement activation: C3a/C5a (anaphylatoxins), C3b (opsonins) -> further inflammation
  5. Coagulation activation: Factor XII + altered endothelial function -> DIC
  6. Immunosuppression oscillation: Counter-regulatory shift from Th1 to anti-inflammatory cytokines (IL-10, soluble TNF receptor) -> patients oscillate between hyperinflammatory and immunosuppressed states
Three primary effects of septic shock to address:
  • Hypovolemia (absolute from GI losses/sweating + relative from venous capacitance + capillary leak)
  • Direct myocardial depression (TNF-alpha, IL-1beta, iNOS, mitochondrial dysfunction)
  • Systemic inflammation -> ARDS, AKI, liver failure
  • Robbins, Cotran & Kumar Pathologic Basis of Disease, p. 135; Rosen's Emergency Medicine, p. 59

Morphologic Effects (Organ Pathology)

OrganFinding
BrainIschemic encephalopathy
HeartSubendocardial hemorrhage/necrosis
KidneyAcute tubular necrosis ("shock kidney") - fibrin thrombi in glomeruli
AdrenalsCortical cell lipid depletion (increased steroid synthesis)
LungDiffuse alveolar damage ("shock lung"/ARDS) - especially in septic/traumatic shock
GI tractMucosal hemorrhage, ulceration, bacterial translocation
Neuronal and cardiomyocyte loss is irreversible; most other tissues can recover if the patient survives. - Robbins, Cotran & Kumar, p. 135

Clinical Features

FindingHypovolemic/CardiogenicSeptic (early)
SkinCool, clammy, cyanoticWarm, flushed
PulseWeak, rapidBounding initially
BPHypotensionMay be normal early
Mental statusConfusion, obtundationVariable
Urine output<0.5 mL/kg/h (severe)Decreased
LactateElevated (>4 mmol/L)Elevated
Diagnostic criteria (Rosen's Box 3.3):
  • Septic shock: Sepsis + hypotension requiring vasopressors after fluid loading + lactate >2 mmol/L
  • Hemorrhagic shock: Suspected bleeding with base deficit <4 mEq/L or HR >100 consistently
  • Cardiogenic shock: Cardiac failure + shock criteria

Monitoring

  • Urine output - most reliable index of vital organ perfusion; normal = 1.0 mL/kg/h; <0.5 mL/kg/h = severe renal hypoperfusion
  • Lactate - serial measurement; persistent elevation = ongoing shock
  • Base deficit - worsening base deficit + rising lactate + low UO = persistent or worsening shock
  • Bedside ultrasound (FAST/echo) - screens for tamponade, LV/RV dysfunction, fluid volume

Management Principles

General Approach

  1. Secure airway and IV access (2 large-bore IVs or central line)
  2. Identify and treat the underlying cause (source control in sepsis, PCI in cardiogenic, hemorrhage control in hypovolemic)
  3. Restore tissue perfusion with targeted resuscitation

Type-Specific Treatment

Hemorrhagic Shock:
  • Preferentially treated with blood products using a balanced transfusion approach - pRBC : FFP : platelets in a 1:1:1 ratio
  • Avoid excessive crystalloid (worsens coagulopathy)
  • Damage control surgery for ongoing bleeding
Septic Shock (Surviving Sepsis Bundle):
  • Early balanced fluid resuscitation (crystalloid; 30 mL/kg bolus as initial guide)
  • Vasopressors (norepinephrine first-line) to target MAP ≥65 mmHg
  • Prompt antimicrobial therapy (within 1 hour of recognition)
  • Source control (drain abscess, remove infected device)
  • Steroids (hydrocortisone) if refractory to vasopressors
Cardiogenic Shock:
  • Treat underlying cause (primary PCI for STEMI)
  • Inotropes (dobutamine, milrinone)
  • Mechanical circulatory support (IABP, Impella, ECMO) in refractory cases
  • Avoid aggressive fluid loading (worsens pulmonary edema)
Neurogenic Shock:
  • IV fluids + vasopressors (norepinephrine or phenylephrine)
  • Atropine for symptomatic bradycardia
  • Spinal immobilization, definitive spine management
Anaphylactic Shock:
  • Epinephrine IM (0.3-0.5 mg) is first-line - immediately
  • Antihistamines (H1 + H2 blockers) as adjuncts
  • Steroids to prevent biphasic reaction
  • IV fluids for volume support
  • Rosen's Emergency Medicine, p. 58-61; Sabiston Textbook of Surgery, p. 563

Summary Table

TypeCOSVRPCWPCVPTreatment
HypovolemicLowHighLowLowFluids / blood products
CardiogenicLowHighHighHighInotropes / PCI / MCS
Distributive/SepticHigh (early)LowLowLowFluids + vasopressors + antibiotics
ObstructiveLowHighVariableHighRelieve obstruction
NeurogenicLow/normalLowLowLowFluids + vasopressors
CO = cardiac output; SVR = systemic vascular resistance; PCWP = pulmonary capillary wedge pressure; CVP = central venous pressure

Recent Evidence: A 2024 review in Intensive Care Medicine (PMID: 39254735) covers the state-of-the-art management of cardiogenic shock, including mechanical circulatory support strategies. A 2025 review (PMID: 39720581) addresses the emerging entity of mixed cardiogenic-vasodilatory shock, which is increasingly recognized in ICU patients.
This is a shared conversation. Sign in to Orris to start your own chat.